Trials / Unknown
UnknownNCT02579304
Diagnostic Value of Transbronchial Lung Cryobiopsy
Feasibility, Safety and Diagnostic Value of Transbronchial Lung Cryobiopsy in the Work-up of Diffuse Interstitial Lung Diseases.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (estimated)
- Sponsor
- KU Leuven · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Evaluating the diagnostic value of transbronchial lung cryobiopsy (TBLC) as well as its procedural feasibility and safety in a prospective series of 20 patients with diffuse interstitial lung diseases (DILD) who are referred for invasive histopathological diagnostics
Detailed description
Before one is able to state that TBLC is a technique that is an alternative for VATS biopsy, the diagnostic value of TBLC should be assessed and the value of the histopathological sampling should be compared with what is achieved by surgical lung biopsy. For this purpose direct comparison between VATS biopsy and TBLC is unavoidable. By including TBLC in the work-up of patients with DILD in which histopathological assessment is indicated (as proposed by MDD), we want to assess 3 major points of concern. Agreement for the histopathological diagnosis between VATS biopsy and TBLC. Value of TBLC in the specific diagnosis in ILD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | transbronchial lung cryobiopsy | bronchoscopic sampling |
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2022-12-01
- Completion
- 2023-06-01
- First posted
- 2015-10-19
- Last updated
- 2018-05-24
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT02579304. Inclusion in this directory is not an endorsement.